Sood Nitin
Officer at ADPT
- Sold, on record
- $690k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 8, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ADPTAdaptive Biotechnologies CorpOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ADPTPlan not statedAug 5, 2022 2022
Sold 17,540 shares at $10.98 ($193k)
Sood Nitin, Chief Commercial Officer, MRD
Sold 10.8% of holdings ($1.8M position)145,571 shares leftFirst sale on recordFiling
- 2 Form 4 sale ADPTPlan not statedNov 1, 2022 +88 days
Sold 31,066 shares at $8.00 ($249k)
Sood Nitin, Chief Commercial Officer, MRD
Sold 21.3% of holdings ($1.2M position)114,505 shares leftFiling
- 3 Form 4 sale ADPTPlan not statedMar 7, 2023 +126 days
Sold 16,474 shares at $8.59 ($141k)
Sood Nitin, Chief Commercial Officer, MRD
Sold 6.7% of holdings ($2.1M position)231,010 shares leftFiling
- 4 Form 4 sale ADPTRoutineAug 8, 2023 +154 days
Sold 16,202 shares at $6.62 ($107k)
Sood Nitin, Chief Commercial Officer, MRD
10b5-1 planSold 7% of holdings ($1.5M position)214,808 shares left0.9x usual sizeFollows a Form 144Filing
- 5 Form 144 notice ADPTNoticeAug 8, 2023 same day
Filed to sell 10,550 shares ($69k)
Sood Nitin, Officer
10b5-1 plan0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | Aug 8, 2023 | ADPT | Officer | Form 144 notice | 10,550 | $69k | Notice | SEC | |
| Aug 8, 2023 | Aug 8, 2023 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 16,202 | $107k | 7.0% | Routine | SEC |
| Mar 7, 2023 | Mar 8, 2023 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 16,474 | $141k | 6.7% | Plan not stated | SEC |
| Nov 1, 2022 | Nov 1, 2022 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 31,066 | $249k | 21.3% | Plan not stated | SEC |
| Aug 5, 2022 | Aug 5, 2022 | ADPT | Chief Commercial Officer, MRD | Form 4 sale | 17,540 | $193k | 10.8% | Plan not stated | SEC |